Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Dec;93(12):6460-6461.
doi: 10.1002/jmv.27235. Epub 2021 Aug 2.

Introduction of SARS-COV-2 C.37 (WHO VOI lambda) from Peru to Italy

Affiliations
Case Reports

Introduction of SARS-COV-2 C.37 (WHO VOI lambda) from Peru to Italy

Andreina Baj et al. J Med Virol. 2021 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest.

References

    1. Focosi D, Maggi F. Neutralising antibody escape of SARS‐CoV‐2 spike protein: risk assessment for antibody‐based Covid‐19 therapeutics and vaccines. Rev Med Virol. 2021. 10.1002/rmv.2231 - DOI - PMC - PubMed
    1. Tracking SARS‐CoV‐2 variants. https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/
    1. Koenig P‐A, Das H, Liu H, et al. Structure‐guided multivalent nanobodies block SARS‐CoV‐2 infection and suppress mutational escape. Science. 2021;371(6530):eabe6230. 10.1126/science.abe6230 - DOI - PMC - PubMed
    1. Starr TN, Greaney AJ, Dingens AS, Bloom JD. Complete map of SARS‐CoV‐2 RBD mutations that escape the monoclonal antibody LY‐CoV555 and its cocktail with LY‐CoV016. Cell Rep Med. 2021;2(4):100255. 10.1101/2021.02.17.431683 - DOI - PMC - PubMed
    1. Tada T, Zhou H, Dcosta BM, Samanovic MI, Mulligan MJ, Landau NR. SARS‐CoV‐2 lambda variant remains susceptible to neutralization by mRNA vaccine‐elicited antibodies and convalescent serum. bioRxiv. Published online July 03, 2021. 10.1101/2021.07.02.450959 - DOI

Substances